We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cobra Bio-Man. | LSE:CBF | London | Ordinary Share | GB0031704835 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.25 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMCBF
RNS Number : 2295E
Cobra Bio-Manufacturing PLC
16 December 2009
+-------------------------------------+-------------------------------------+
| For Immediate Release | 16 December 2009 |
+-------------------------------------+-------------------------------------+
Cobra Biomanufacturing Plc ("Cobra" or "the Group" or "the Company")
Re Announcement by Recipharm AB ("Recipharm")
The Board of Cobra Biomanufacturing Plc, notes the announcement issued today by
Recipharm in relation to a mandatory cash offer for the Company at 2.25p per
ordinary share.
Trading conditions have remained very challenging with the continued delay in
the achievement of contract signatures and as a result the Company does not have
sufficient working capital for its current purposes. However, in accordance with
the City Code, it is envisaged that Recipharm will loan monies on normal
commercial terms to Cobra, in order for Cobra to meet its working capital
requirements during the integration of the Recipharm and Cobra businesses.
A further announcement will be made in due course.
For further information, please contact:
+------------------------------------------------+--------------------------+
| Cobra Biomanufacturing Plc | Tel: +44 (0) 1782 714 |
| | 181 |
+------------------------------------------------+--------------------------+
| Danny Chapchal, Chairman | |
+------------------------------------------------+--------------------------+
| Simon Saxby, Chief Executive | |
+------------------------------------------------+--------------------------+
| Peter Coleman, Finance Director | |
+------------------------------------------------+--------------------------+
| | |
+------------------------------------------------+--------------------------+
| Buchanan Communications | Tel: +44 (0) 207 466 |
| | 5000 |
+------------------------------------------------+--------------------------+
| Tim Anderson | |
+------------------------------------------------+--------------------------+
| | |
+------------------------------------------------+--------------------------+
| Seymour Pierce (NOMAD & Broker) | Tel: +44 (0) 20 107 8000 |
+------------------------------------------------+--------------------------+
| Chris Howard | |
+------------------------------------------------+--------------------------+
| Christopher Wren | |
+------------------------------------------------+--------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
STRUNRSRKRRUAAA
1 Year Cobra Bio-manufacturing Chart |
1 Month Cobra Bio-manufacturing Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
